The gains in Morepen Labs come on the back of a positive business development announced by the company today involving the first phase of its manufacturing capacity expansion program.
Morepen Laboratories' share price hit a multi-year high of ₹112.85, soaring 8 per cent on the BSE in Wednesday's intra-day trade.
Morepen Laboratories today announced that its PAT surged by 394 per cent Y-o-Y to ₹56.35 crore in the June quarter, supported by better operating leverage and improved performance on API front.